House of Lords Business
Show full summary

Lord Mendelsohn to ask His Majesty's Government, further to the Written Answer by Lord Markham on 2 February (HL4910), when the next Therapeutics Clinical Review Panel is scheduled to meet to consider more recent evidence on COVID-19 risk; and who are the members of that panel. 

Question HL5695: tabled on 20 February 2023 and due for answer by 6 March 2023

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Mendelsohn to ask His Majesty's Government, further to the Written Answer by Lord Markham on 2 February (HL4910), when the next Therapeutics Clinical Review Panel is scheduled to meet to consider more recent evidence on COVID-19 risk; and who are the members of that panel.  HL5695
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Date Answered

Tuesday 7 March 2023

Member's Registered Interests

There are no interests to show.

Main Member

Lord Mendelsohn
Labour
Life peer